GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » NanoRepro AG (XTER:NN6) » Definitions » Total Equity

NanoRepro AG (XTER:NN6) Total Equity : €39.02 Mil (As of Jun. 2024)


View and export this data going back to 2008. Start your Free Trial

What is NanoRepro AG Total Equity?

NanoRepro AG's total equity for the quarter that ended in Jun. 2024 was €39.02 Mil.

This is Residual interest, including minority interest, that remains in the assets of the enterprise after deducting its liabilities. Equity is increased by owners’ investments and by comprehensive income, and it is reduced by distributions to the owners.


NanoRepro AG Total Equity Historical Data

The historical data trend for NanoRepro AG's Total Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NanoRepro AG Total Equity Chart

NanoRepro AG Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.43 7.99 57.61 47.43 40.38

NanoRepro AG Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 51.36 47.43 42.79 40.38 39.02

NanoRepro AG Total Equity Calculation

Total Equity and Total Liabilities are the two components for Total Assets.

NanoRepro AG's Total Equity for the fiscal year that ended in Dec. 2023 is calculated as

Total Equity=Total Assets(Q: Dec. 2023 )-Total Liabilities(Q: Dec. 2023 )
=41.458-1.082
=40.38

NanoRepro AG's Total Equity for the quarter that ended in Jun. 2024 is calculated as

Total Equity=Total Assets(Q: Jun. 2024 )-Total Liabilities(Q: Jun. 2024 )
=39.749-0.728
=39.02

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


NanoRepro AG Total Equity Related Terms

Thank you for viewing the detailed overview of NanoRepro AG's Total Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


NanoRepro AG Business Description

Traded in Other Exchanges
Address
Untergasse 8, Marburg, DEU, 35037
NanoRepro AG is engaged in the development, manufacturing, and distribution of CE-certified rapid diagnostic tests (self-tests) and food supplements for both, home and professional use.
Executives
Dr. Olaf Stiller Supervisory Board
Andre Schulte-südhoff Supervisory Board
Lisa Jüngst Board of Directors
Michael Tillmann Supervisory Board

NanoRepro AG Headlines

No Headlines